Enrique Poradosu - Jan 3, 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Science & Business Off
Signature
/s/ Enrique Poradosu
Stock symbol
NVCT
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 04:31 PM
Previous filing
Mar 28, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +130K +9.46% $0.00 1.5M Jan 3, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock will vest according to the following schedule: one-third on each of 01/3/2025, 01/3/2026, and 01/3/2027.
F2 Includes 353,399 shares of restricted stock.